Oprozomib (CAS 935888-69-0)

20S Proteasome α2, 20S Proteasome α3, 20S Proteasome α6, 20S Proteasome α7, 20S Proteasome α8, 20S Proteasome β1, 20S Proteasome β2, 20S Proteasome β3, 20S Proteasome β5, 20S Proteasome β7, 26S Proteasome, 26S Proteasome α, 26S Proteasome p42C, 26S Proteasome p48A, 26S Proteasome p50, 26S Proteasome p54, 26S Proteasome p58, 4931431F19Rik, 4933422H20Rik, APC11, APC2, ASB-2, AV320801, BTBD2, BTBD6, C4orf30, C6orf113, CCP5, Cdc23, CSN7a, CSN7b, Dda1, DDI2, Derlin-1, Dorfin, E2ig5, EG382106, EG382156, EG668359, Fbxo12, Fbxo12J, FBXO21, FBXO41, Fbxw13, Fbxw16, FBXW17, Fbxw19, FBXW23, Gigaxonin, Gm514, GMCL1L, HECTD4, Herc1, Herc2, Ig κ light chain, Josephin-2, KBTBD4, KCMF1, KLHDC10, KLHDC4, KLHDC6, KLHL33, LNX1, LONRF1, LONRF3, LRRC41, LRSAM1, MECL-1, MIB1, NEDL1, NEURL4, NHLRC3, NOB1P, Nulp1, PA, PARC, PGPEP1L, PIH1D2, Proteassemblin, PSMB4, PSMB6, PSMC1, PSMC2, PSMC4, PSMD11, PSMD12, PSMD3, PSMD5, PSMD7, PSMD8, PSME proteasome activator subunits (PA28), Rad23, RNF103, RNF113A1, RNF121, RNF130, RNF148, RNF152, RNF166, RNF180, RNF182, RNF187, RNF219, RNF24, RNF32, Rpn11, SEL-10, SHFM3, Slimb, SUG1, TIP120B, TRIM11, TRIM23, TRIM31, TRIM37, TRIM40, TRIM45, TRIM47, TRIP15, UBC2, UBCE7IP4, UBE2CBP, UBE3B, UBE4A, UBQLN3, Ubr2, Ubr3, UBXD7, USP21, USP29, Vta1, WDR20a, ZFAND1, ZFAND2B, ZFP91, ZNF114, und ZNF121.

20S Proteasome α5, 20S Proteasome α6, A1Up, ASB-1, ASB-7, CRLF3, ECM29, FBL12, FBL13, Fbxo12J, FBXO35, Fbxw13, Neuralized-2, PCNP, PI31, POH1, PSMD2, PSMD8, Rad23A, SVIP, UBAP1, und UCH-L3.